183 related articles for article (PubMed ID: 9123375)
21. Flow Cytometry Panel-Reactive Antibody Screening of Anti-HLA Antibodies in the Waiting List Significantly Reduces the Occurrence of Acute Rejection After Kidney Transplantation.
Dedinská I; Mäčková N; Macháleková K; Miklušica J; Palkoci B; Fialová J; Čellár M; Galajda P; Mokáň M
Transplant Proc; 2017 Oct; 49(8):1719-1723. PubMed ID: 28923614
[TBL] [Abstract][Full Text] [Related]
22. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
[TBL] [Abstract][Full Text] [Related]
23. Immunoadsorption with protein A in humoral acute rejection of kidney transplants: multicenter experience.
Mastrangelo F; Pretagostini R; Berloco P; Poli L; Cinti P; Patruno P; Alfonso L; Pompei L; Carboni F; Rizzelli S
Transplant Proc; 1995 Feb; 27(1):892-5. PubMed ID: 7879221
[No Abstract] [Full Text] [Related]
24. Presence of IgG HLA antibodies in patients with long-surviving renal allografts.
Norman PJ; Harmer AW; Koffman CG; Vaughan RW
Transplant Proc; 1995 Feb; 27(1):999-1000. PubMed ID: 7879260
[No Abstract] [Full Text] [Related]
25. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
[TBL] [Abstract][Full Text] [Related]
26. Specific HLA antibody production following renal transplantation.
Martin S; Dyer PA; Gokal R; Mallick NP; Johnson RW
Transplant Proc; 1987 Feb; 19(1 Pt 1):898. PubMed ID: 3274885
[No Abstract] [Full Text] [Related]
27. Treatment of acute humoral rejection in kidney transplantation with plasmapheresis.
Grandtnerová B; Javorský P; Kolácný J; Hovoricová B; Dĕdic P; Laca L
Transplant Proc; 1995 Feb; 27(1):934-5. PubMed ID: 7879238
[No Abstract] [Full Text] [Related]
28. Application of Prastat ELISA in the determination of anti-HLA specificity for immunized patients awaiting kidney transplant: five years' experience.
Buscaroli A; De Sanctis LB; Iannelli S; Stipo L; Bertuzzi V; Raimondi C; Mosconi G; Liviano D' Arcangelo G; Scolari MP; Stefoni S
Transpl Int; 2000; 13 Suppl 1():S99-105. PubMed ID: 11111973
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometric evaluation of pregnancy-induced anti-donor immunization.
Ayna TK; Ciftci HS; Tozkir H; Sagiroglu T; Isitmangil G; Gurtekin B; Gurtekin M
Transplant Proc; 2012; 44(6):1656-9. PubMed ID: 22841238
[TBL] [Abstract][Full Text] [Related]
30. Human leukocyte antigen and major histocompatibility complex class I-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients.
Seyhun Y; Ozdilli K; Oguz F; Karahan G; Onal E; Turkmen A; Eldegez U; Nane I; Çalişkan Y; Bakkaloglu H; Carin M
Transplant Proc; 2012; 44(6):1660-6. PubMed ID: 22841239
[TBL] [Abstract][Full Text] [Related]
31. Effect of anti-HLA and anti-idiotypic antibodies on the long-term survival of heart and kidney allografts.
Reed E; Cohen DJ; Barr ML; Ho E; Marboe CC; Rose EA; Hardy M; Suciu-Foca N
Transplant Proc; 1992 Dec; 24(6):2494-5. PubMed ID: 1465842
[TBL] [Abstract][Full Text] [Related]
32. Outcome of kidney transplants in patients known to be flow cytometry crossmatch positive.
Scornik JC; Clapp W; Patton PR; Van der Werf WJ; Hemming AW; Reed AI; Howard RJ
Transplantation; 2001 Apr; 71(8):1098-102. PubMed ID: 11374409
[TBL] [Abstract][Full Text] [Related]
33. Negative crossmatch on current sera and good HLA matching are the main requirements for renal transplantation in highly sensitized patients.
Cristol JP; Mourad G; Argiles A; Seignalet J; Iborra F; Ramounau-Pigot A; Chong G; Mion C
Transplant Proc; 1992 Dec; 24(6):2470-1. PubMed ID: 1465835
[No Abstract] [Full Text] [Related]
34. Defining the immunogenicity and antigenicity of HLA epitopes is crucial for optimal epitope matching in clinical renal transplantation.
Kramer CSM; Roelen DL; Heidt S; Claas FHJ
HLA; 2017 Jul; 90(1):5-16. PubMed ID: 28378521
[TBL] [Abstract][Full Text] [Related]
35. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
[TBL] [Abstract][Full Text] [Related]
36. A novel post-transplant alloantibody surveillance and intervention strategy that improves graft outcomes in sensitized renal transplant recipients.
Kimball PM; King A
Clin Transpl; 2011; ():369-72. PubMed ID: 22755433
[TBL] [Abstract][Full Text] [Related]
37. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques.
Piazza A; Poggi E; Borrelli L; Servetti S; Monaco PI; Buonomo O; Valeri M; Torlone N; Adorno D; Casciani CU
Transplantation; 2001 Apr; 71(8):1106-12. PubMed ID: 11374411
[TBL] [Abstract][Full Text] [Related]
38. Influence of recipient's HLA type on the outcome of renal transplantation.
Forsberg B; Ekberg H; Johnson U
Transplant Proc; 1992 Dec; 24(6):2463-5. PubMed ID: 1465832
[No Abstract] [Full Text] [Related]
39. Use of Single-Antigen Flow Beads Assays to Assess Anti-HLA Donor-Specific Antibody Strength.
Loiseau P; Amokhrane K; Visentin J; Kheav VD; Caillat-Zucman S; Taupin JL
Biol Blood Marrow Transplant; 2016 Feb; 22(2):394-395. PubMed ID: 26597077
[No Abstract] [Full Text] [Related]
40. Detection of allo- and autoantibodies in kidney transplantation by flow cytometry.
Rodríguez PC; Palacio JL; Arango L; Henao JE; García LF
Transplant Proc; 1999; 31(1-2):282-4. PubMed ID: 10083109
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
